BN II System
BN II System

The BN™ II System and its nephelometric technology provide uncompromising performance in plasma protein analysis. The menu covers assays to support a variety of clinical indications, such as cardiac risk assessment, kidney diseases, nutritional assessment, and innovative markers such as monoclonal kappa and lambda free light chains, Cystatin C and Carbohydrate-Deficient Transferrin (CDT).

  • Ideal for mid- to high-volume plasma protein throughput
  • Comprehensive menu from one source: Over 64 assay protocols available for determination of various sample types
  • Up to 100 samples onboard
  • Antigen-excess security for confidence in results
  • Assistance with clinical interpretation through our innovative range of assessment programs available for Protis® Data Management System*
Our Products
Diamond Stone Investment
We are a young and aggressive company dedicated to becoming a market leader in the implementation of the latest technologies and treatments in medicine. The partners of Diamond Stone Investment have been working in Medical Healthcare area more than 20 years In a few years we have achieved our goal of building a trust pyramid with our customers. We have achieved our goals by focusing on providing the best services to our clients regardless of profit. Again, one of our strongest points is our experienced technical service team.
Our References
×
×